EGFR and glioblastoma: The group then advanced the diagnostic use of anti-EGFR aptamers with two subsequent articles on the tracking of the differential dynamics of GBM cell morphology on aptamer-grafted substrates, and on the analysis of dynamic morphology in computational single-cell metrics to detect and recognize tumor cells [22,29].